Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-012647

Director bought 1,203 shares at $3.20 ($3,850)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2022-03-02 Purchase +1,203 $3.20 $3,850 5,231,488 I
Open-market purchases · 1,203 sh · avg $3.20 · $3,850
Loading xslF345X03/doc1.xml…